Table 2.

Patient characteristics (alloSCT patients) with positive HCMV real-time PCR result

Patient No.	Age and Sex	Disease	Donor	Underlying disease	Day of first positive RT-PCR result	Peak HCMV level (copies/ml)	Recurrence	HCMV Serostatus (D/R)	GVHD	Outcome
1	42 M	AML	Sister	+	38	88,600 ± 15	–	−/ -	–	Alive (Hematuria)
2	32 M	ALL	Mud	–	23	4000 ± 8	–	−/+	–	Alive (Liver disorders)
3	48 M	MM	Brother	–	96	64 ± 1	–	+/ +	–	Alive
4	56 M	AML	Brother	–	10	230 ± 2	+	+/ +	Skin	Alive
5	40 M	AML	Brother	–	4	835 ± 1	–	+/ +	–	Alive
6	33F	ALL	Brother	–	4	480 ± 2	–	−/ -	GI	Alive
7	41 M	ALL	Brother	+	10	563 ± 3	–	−/ +	Skin	Alive
8	42 M	ALL	Brother	–	100	670 ± 1	–	+/ +	Compound	Alive
9	21 M	AML	Brother	–	40	120 ± 1	–	−/ +	Compound	Alive
10	37 M	AML	Brother	–	7	300 ± 1	–	+/ +	–	Alive
11	26 M	AML	Brother	–	28	117,413 ± 16	–	+/ +	–	Alive (Diarrhea)
12	50 M	AML	Mud	+	56	580 ± 1	+	−/ +	Compound	Alive
13	46 M	AML	Sister	–	30	4320 ± 3	–	−/ +	–	Died Of Fungal Complications
14	53 M	MF	Mud	+	9	8310 ± 11	+	−/ +	Compound	Alive (CNS disorders)
15	57F	AML	Mud	+	12	315 ± 2	–	−/ +	Compound	Alive
16	39 M	AML	Brother	–	8	23 ± 0	–	+/ +	Skin	Alive
17	46F	ALL	Brother	+	19	191 ± 0	–	+/ +	GI	Alive
18	46F	AML	Mud	–	18	325,967 ± 25	+	+/ +	GI	Alive (Pneumonitis)
19	58F	MM	Mud	–	38	6174 ± 13	–	+/ +	Skin	Alive (Digestive disorders)
20	30 M	MM	Sister	+	11	39 ± 0	–	−/ -	–	Alive
21	31F	MM	Mud	–	26	6579 ± 5	+	+/ +	GI	Alive (Hemorrhagic cystitis, Kidney failure)
22	55F	NHL	Sister	–	25	452 ± 1	–	+/ -	–	Dead (Pneumonitis)
23	67 M	AML	Sister	–	31	250 ± 2	–	−/ -	–	Alive

MUD Matched Unrelated Donor, R- Recipient HCMV negative, D- Donor HCMV negative, R+ Recipient HCMV positive, D+ Donor HCMV positive, HCMV Cytomegalovirus, AML Acute Myeloid Leukemia, CML Chronic Myeloid Leukemia, ALL Acute Lymphoblastic Leukemia, MM Multiple Myeloma, HL Hodgkin Lymphoma, NHL Non-Hodgkin Lymphoma, MF Myelofibrosis, GVHD Graft-Versus-Host Disease, PCR Polymerase Chain Reaction